Sermorelin (10MG)
$100.00
Semorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Supplied as a lyophilized powder, it is intended exclusively for in vitro laboratory research and analytical applications. Semorelin is commonly used to study peptide–receptor interactions, ligand binding dynamics, and intracellular signaling pathways under controlled experimental conditions.
Semorelin is a well-characterized synthetic peptide employed in laboratory research to investigate GHRH receptor dynamics, peptide stability, and structure–activity relationships. Its defined sequence allows precise evaluation in in vitro biochemical and assay-based studies. The lyophilized format ensures stability, reproducibility, and safe handling in non-clinical research studies.
Research Applications
Semorelin is suitable for in vitro studies including:
Analysis of GHRH receptor binding and signaling pathways
Modeling peptide–receptor interactions and ligand dynamics
Evaluation of intracellular signaling cascades associated with GHRH analogs
Structure–activity relationship studies of synthetic peptide analogs
Assessment of stability, degradation, and analytical profiling in assay-based systems
Storage and Handling
Store lyophilized powder at −20 °C
After reconstitution, maintain at 2–8 °C and use promptly
Avoid repeated freeze-thaw cycles
Follow aseptic techniques during laboratory handling
Product Specifications
Purity: ≥99 % (HPLC Certified)
Appearance: White lyophilized powder
Solubility: Soluble in appropriate laboratory solvents
Compliance Notice
For research use only. Not intended for human or veterinary use. This product has not been evaluated by the FDA. Misuse may violate federal, state, or local laws. By purchasing, the buyer confirms use strictly for in vitro research purposes.
